Seeking Clues to BioMarin (BMRN) Q4 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 02/19/24
BioMarin to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Thursday, February 22, 2024, at 4:30pm ETPRNewsWire • 02/08/24
BioMarin to Present ROCTAVIAN™ (valoctocogene roxaparvovec-rvox) Data Highlighting Long-Term Durability at 2024 European Association for Haemophilia and Allied Disorders (EAHAD) CongressPRNewsWire • 02/06/24
BioMarin Pharmaceutical (BMRN) is a Top-Ranked Growth Stock: Should You Buy?Zacks Investment Research • 01/15/24
If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 NamesInvestorPlace • 01/10/24
BioMarin to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, at 10:30 am PT / 1:30 pm ET, in San Francisco, CAPRNewsWire • 01/03/24
BioMarin Announces Agreement with German Health Insurance Fund on Reimbursement Amount for ROCTAVIAN® (valoctocogene roxaparvovec-rvox) for Severe Hemophilia A in GermanyPRNewsWire • 11/28/23
BioMarin Surges As Activist Investor Elliott Reportedly Builds $1 Billion StakeInvestors Business Daily • 11/07/23
4 Unique Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market DipThe Motley Fool • 11/04/23
BioMarin Announces Strong Third Quarter 2023 Results, Including Continued Profitability, and 15% Total Revenue Growth Year Over YearPRNewsWire • 11/01/23
BioMarin Announces Retirement of Jean-Jacques Bienaimé; Appoints Alexander Hardy President and Chief Executive OfficerPRNewsWire • 11/01/23